Clinical Trial Update: TACE Using Doxorubicin-eluting Beads for Patients With HCC and Marginal Hepatic Reserve [NA]

View source ↗

Summary

Clinical trial update on doxorubicin-eluting bead chemoembolization for hepatocellular carcinoma with marginal hepatic reserve; study terminated with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Doxorubicin-eluting beads (doxorubicin-eluting beads)

Snippet

Sponsor: University of California, San Francisco | Conditions: Hepatocellular Carcinoma, Chemoembolization | NA | Status: TERMINATED | Results posted: 2019-09-10